Vertex Pharmaceuticals (VRTX) Current Leases (2016 - 2018)
Historic Current Leases for Vertex Pharmaceuticals (VRTX) over the last 7 years, with Q4 2018 value amounting to $9.8 million.
- Vertex Pharmaceuticals' Current Leases fell 5642.89% to $9.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was $9.8 million, marking a year-over-year decrease of 5642.89%. This contributed to the annual value of $9.8 million for FY2018, which is 5642.89% down from last year.
- According to the latest figures from Q4 2018, Vertex Pharmaceuticals' Current Leases is $9.8 million, which was down 5642.89% from $11.5 million recorded in Q3 2018.
- In the past 5 years, Vertex Pharmaceuticals' Current Leases registered a high of $22.5 million during Q4 2017, and its lowest value of $9.8 million during Q4 2018.
- Over the past 5 years, Vertex Pharmaceuticals' median Current Leases value was $17.8 million (recorded in 2014), while the average stood at $17.1 million.
- As far as peak fluctuations go, Vertex Pharmaceuticals' Current Leases skyrocketed by 12070.59% in 2014, and later crashed by 5642.89% in 2018.
- Vertex Pharmaceuticals' Current Leases (Quarter) stood at $17.8 million in 2014, then decreased by 12.7% to $15.5 million in 2015, then grew by 24.97% to $19.4 million in 2016, then grew by 15.98% to $22.5 million in 2017, then tumbled by 56.43% to $9.8 million in 2018.
- Its Current Leases was $9.8 million in Q4 2018, compared to $11.5 million in Q3 2018 and $15.1 million in Q2 2018.